Faculty profile
Tal Schechter-Finkelstein
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
Successful Myeloablative Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in a Young Girl With GATA2 Deficiency and Emberger Syndrome.
Journal of pediatric hematology/oncology · 2017
Latest funding
- $929,478
Kidney and blood pressure disease burden and monitoring for chronic kidney disease in childhood cancer survivors
CIHR · 2019 · Co-investigator
- $514,465
A randomized controlled trial of individualized yoga to reduce fatigue in hospitalized children receiving intensive chemotherapy
CIHR · 2018 · Co-investigator
- $933,300
Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant
CIHR · 2017 · Co-investigator
1 publications.
Successful Myeloablative Matched Unrelated Donor Hematopoietic Stem Cell Transplantation in a Young Girl With GATA2 Deficiency and Emberger Syndrome.
Ramzan M, Lowry J, Courtney S, Krueger J, Schechter Finkelstein T, Ali M
Kidney and blood pressure disease burden and monitoring for chronic kidney disease in childhood cancer survivors
Principal investigators: Zappitelli, Michael
Keywords: Administrative Health Care; Cancer Therapy; Children; Chronic Kidney Disease; Epidemology; Hypertension; Knowledge Translation; Long-Term Outcomes; Population-Based Study; Prospective Cohort
A randomized controlled trial of individualized yoga to reduce fatigue in hospitalized children receiving intensive chemotherapy
Principal investigators: Sung, Lillian
Keywords: Cancer; Fatigue; Hematopoietic Stem Cell Transplantation; Multi-Centre; Opioid; Pediatric; Quality Of Life; Randomized-Trial; Yoga
Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant
Principal investigators: Dupuis, L. L
Keywords: Chemotherapy-Induced Nausea; Chemotherapy-Induced Vomiting; Hematopoietic Stem Cell Transplant; Olanzapine; Oncology; Pediatric; Supportive Care
Randomized, Placebo-Controlled Study of Olanzapine for the Control of Chemotherapy-induced Vomiting (CIV) in Children Receiving Cyclophosphamide-based Conditioning for Allogeneic Hematopoietic Stem Cell Transplant
Principal investigators: Dupuis, L. L
Keywords: Chemotherapy-Induced Vomiting; Hematopoietic Stem Cell Transplant; Olanzapine; Pediatrics; Supportive Care
The Canadian National Transplant Research Program: Increasing Donation and Improving Transplantation Outcomes
Principal investigators: West, Lori J; Caulfield, Timothy A; Hébert, Marie-Josée; Humar, Atul; Knoll, Gregory; Levings, Megan K; Mital, Seema; Roy, Denis-Claude; Schultz, Kirk R; Shapiro, James
Keywords: Bone Marrow; Increasing Donation; Inflammation; Organ Repair; Pediatrics; Solid Organs/Cells; Stem Cells; Tolerance/Immunomodulation; Transplant Complications; Transplantation
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke, Brain Canada and the New Frontiers in Research Fund.
- Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants
Principal investigator · Terminated · Phase 2 · started 2009 · NCT01135537
From ClinicalTrials.gov: trials with a site in Canada that they lead overall or at a Canadian site.
Frequent collaborators
- Muhammad Ali and Joerg Krueger: 18 shared papers
- Muhammad Ali and Tal Schechter-Finkelstein: 1 shared paper
- Tal Schechter-Finkelstein and Joerg Krueger: 1 shared paper
- Department of Paediatrics
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.